They are designed to act like one of these hormones, known as glucagon-like peptide 1 (GLP-1). The use of Mounjaro, also known as tirzepatide, was recorded as a contributing factor on Susan’s death certificate which lists multiple organ failure ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.

Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September

A nurse has tragically died after receiving a weight loss injection in what is believed to be the first confirmed fatality linked to the drugs. Susan McGowan, 58, had taken two doses of Mounjaro, which makes people feel fuller sooner, before her death in September. The jabs are available on the NHS, but Ms McGowan purchased hers privately.

Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists, which are being rolled out on the NHS

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.

A nurse’s death has been linked to a weight loss drug which is approved for use on the NHS. Susan McGowan, 58, died on September 4 and had recently taken two doses of the weight loss jab Mounjaro. The drug,

The death of a Scots nurse has been linked to an approved weight loss injection which is available on NHS. Susan McGowan, from North Lanarkshire, took two low-dose injections of tirzepatide, known under the brand name Mounjaro,

Susan McGowan, 58, (pictured) from Lanarkshire, died after taking two low-dose injections of tirzepatide, known under the brand name Mounjaro.